Meteora Capital »

Nkgen Biotech shares owned by Meteora Capital

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Meteora Capital from 13F filings

Historical chart of Meteora Capital investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Meteora Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Meteora Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.3M 1.2M 1.89

More positions owned by Meteora Capital

Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Churchill Capital Corp Vii Com Cl A (CVII)
Roadzen Ord Shs (RDZN)
Altc Acquisition Corp Com Cl A (ALCC)
Mountain & Co I Acquisitn Class A Ord (MCAA)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Everest Consolidator Acq Cor Cl A Com (MNTN)
Dmy Squared Technology Group Cl A Com (DMYY)
Tortoiseecofin Acquisition C Shs Cl A (TRTL)
Slam Corp Cl A Shs (SLAM)
Pyrophyte Acquisition Corp Cl A Ord Shs (PHYT)
Ib Acquisition Corp Unit 03/26/2029
Horizon Space Acqustn I Corp Ordinary Shares (HSPO)
Infint Acquisition Corp Cl A Ord Shs (IFIN)
Investcorp India Acquistn Class A Ord Shs (IVCA)

View all positions for Meteora Capital

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech